These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30697429)

  • 1. Angioedema after thrombolysis with tissue plasminogen activator: an airway emergency.
    Rathbun KM
    Oxf Med Case Reports; 2019 Jan; 2019(1):omy112. PubMed ID: 30697429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach.
    Molinaro G; Gervais N; Adam A
    Stroke; 2002 Jun; 33(6):1712-6. PubMed ID: 12053016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angioedema Secondary to tPA Use in Acute Ischemic Stroke Patient with Hypertension: A Case Report.
    Kim C; Hladik A
    Clin Pract Cases Emerg Med; 2021 May; 5(2):159-162. PubMed ID: 34436994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reactions to recombinant tissue plasminogen activator.
    Alakbarzade V; O'Kane D; Pereira AC
    Pract Neurol; 2020 Feb; 20(1):75-79. PubMed ID: 31273082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angioedema from recombinant TPA administration: case report and pathophysiology review.
    Foster-Goldman A; McCarthy D
    Am J Ther; 2013; 20(6):691-3. PubMed ID: 24247033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration.
    Pahs L; Droege C; Kneale H; Pancioli A
    Ann Emerg Med; 2016 Sep; 68(3):345-8. PubMed ID: 27174372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenecteplase-associated orolingual angioedema: A case report and literature review.
    Pitts JK; Burns DM; Patellos KR
    Am J Health Syst Pharm; 2024 Apr; 81(9):e220-e225. PubMed ID: 38270186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Plasminogen Activator-Induced Angioedema Involving a Posterior Cerebral Artery Infarct: A Case Presentation.
    Duymun S; Reddy V; Bentley E; Bose-Kolanu A
    Am J Case Rep; 2021 Jan; 22():e927137. PubMed ID: 33441533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioedema after rt-PA infusion led to airway emergency: a case report of rescue treatment with fresh frozen plasma.
    Mazzoli CA; D Angelo MI; Simonetti L; Cirillo L; Zini A; Gentile M; Gordini G; Coniglio C
    Braz J Anesthesiol; 2023; 73(2):223-226. PubMed ID: 33932385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icatibant as a Potential Treatment of Life-Threatening Alteplase-Induced Angioedema.
    Cheong E; Dodd L; Smith W; Kleinig T
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):e36-e37. PubMed ID: 29097062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral orolingual angioedema in a patient with sarcoidosis after intravenous thrombolysis due to acute stroke without improvement after treatment with icatibant.
    Wollmach AD; Zehnder D; Schwendinger M; Tarnutzer AA
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-Label Use of Agents for Management of Serious or Life-threatening Angiotensin Converting Enzyme Inhibitor-Induced Angioedema.
    Culley CM; DiBridge JN; Wilson GL
    Ann Pharmacother; 2016 Jan; 50(1):47-59. PubMed ID: 26416949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orolingual Angioedema After Tissue Plasminogen Activator Administration in Patients Taking Angiotensin-Converting Enzyme Inhibitors.
    Burd M; McPheeters C; Scherrer LA
    Adv Emerg Nurs J; 2019; 41(3):204-214. PubMed ID: 31356244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibitor-associated angioedema treated with c1-esterase inhibitor: A case report and review of the literature.
    Erickson DL; Coop CA
    Allergy Rhinol (Providence); 2016 Jan; 7(3):168-171. PubMed ID: 27502825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Use of Fresh Frozen Plasma in Treating Hereditary Angioedema: A Success Story From Pakistan.
    Sabeen Ahmed A; Fayyaz S
    Cureus; 2020 Aug; 12(8):e9669. PubMed ID: 32923264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icatibant in angiotensin-converting enzyme (ACE) inhibitor-associated angioedema.
    Fok JS; Katelaris CH; Brown AF; Smith WB
    Intern Med J; 2015 Aug; 45(8):821-7. PubMed ID: 25944565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic management of angioedema induced by angiotensin-converting enzyme inhibitors.
    Scalese MJ; Reinaker TS
    Am J Health Syst Pharm; 2016 Jun; 73(12):873-9. PubMed ID: 27261237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetric angioneurotic edema associated with thrombolysis for acute stroke.
    Pancioli A; Brott T; Donaldson V; Miller R
    Ann Emerg Med; 1997 Aug; 30(2):227-9. PubMed ID: 9250652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Icatibant for the treatment of orolingual angioedema following the administration of tissue plasminogen activator.
    Brown E; Campana C; Zimmerman J; Brooks S
    Am J Emerg Med; 2018 Jun; 36(6):1125.e1-1125.e2. PubMed ID: 29653785
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.
    Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U
    Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.